SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced ...
Debulking surgery is generally the next step after neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer, but there has been controversy as to whether women should undergo a ...
Racial and Ethnic Disparities in the Use of Postmastectomy Breast Reconstruction: Results From a Population- Based Study Patients with clinical stage I to IIA uterine cancer were randomly assigned to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results